Aquestive Therapeutics
AQST | NASDAQ
$3.76
-$0.15 (-3.84%)
At close: Nov 16, 2026, 4:00 PM ET
$3.78
+$0.02 (+0.53%)
After-hours:
Nov 16, 2026, 7:55 PM ET
-3.84%
(1D)No price chart data available for 1D timeframe.
Rating
36.8
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #608/1021 (Top 60%)
Key Statistics
Market Data
Market Cap $472.59M
1D Range
3.71 3.95
52W Range
2.95 6.62
Valuation (TTM)
PE -5.87
PB -6.67
EV/EBITDA -6.02
Valuation (NTM)
Forward PE N/A
Forward PEG 0.25
Price Target $10.50
Cash Flow
FCF Yield -8.6%
SBC Adj. FCF Yield -10.5%
SBC Impact -21.4%
Margins
Gross Margin 65.3%
Operating Margin -114.1%
FCF Margin -83.3%
Growth (CAGR)
Revenue 3Y | 5Y 0.5% |
0.8%
Dil EPS 3Y | 5Y -15.8% |
23.6%
FCF 3Y | 5Y -7.5% |
-26.7%
Returns
ROA -66.4%
ROE 255.1%
ROIC -54.3%
Financial Health
Net Cash
$82.33M
Current Ratio 6.12
Interest Coverage -3.73
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Aquestive Therapeutics, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing products to address significant unmet medical needs across both the United States and i...
Sector Healthcare
Employees 147
IPO Date Jul 25, 2018
Website www.aquestive.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 3, 2026
EPS
-$0.13
Miss -8.33%
YoY:
+7.14% REV
$7.56M
Miss -31.41%
YoY:
-40.99%Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$10.50
Upside
+179.26%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove AQST